Diletti Roberto, Yetgin Tuncay, Manintveld Olivier C, Ligthart Jurgen M R, Zivelonghi Carlo, Zijlstra Felix, Ribichini Flavio
Department of Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, The Netherlands.
EuroIntervention. 2014 Aug;10 Suppl T:T13-22. doi: 10.4244/EIJV10STA4.
The present article focuses on recent innovations and possible future perspectives in the reperfusion treatment of ST-segment elevation myocardial infarction (STEMI). Among these, the shift from the femoral to the radial vascular access, the recent availability of bioresorbable coronary scaffolds, other innovative forms of stent specifically designed for STEMI patients, the use of cardioprotective strategies, as well as the possibility of including autologous bone marrow stem cell transplantation as part of the treatment of patients with STEMI are described and commented on as a glance into the future.
本文重点关注ST段抬高型心肌梗死（STEMI）再灌注治疗的近期创新及未来可能的前景。其中，阐述并评论了从股动脉血管入路向桡动脉血管入路的转变、生物可吸收冠状动脉支架的近期可用性、专门为STEMI患者设计的其他创新型支架、心脏保护策略的应用，以及将自体骨髓干细胞移植纳入STEMI患者治疗方案的可能性，以此展望未来。
